PI-RADS version 2.1 demonstrated improved detection of clinically significant prostate cancer in the transition zone. For detecting clinically significant prostate cancer (csPCa), prostate imaging ...
Sciencing on MSN
The cancer that's sometimes 'invisible' on an MRI
MRIs are powerful tools in the cancer-fighting arsenal, but despite their efficacy, they aren't infallible, and some cancers ...
PSMA-based PET imaging in newly diagnosed, high-risk localized prostate cancer, a National Cancer Institute (NCI) Cancer Moonshot trial. This is an ASCO Meeting Abstract from the 2025 ASCO ...
In a cohort of US veterans with prostate cancer who were on active surveillance, negative multiparametric MRI had a 75% negative predictive value for ruling out disease of grade group 2 or higher at ...
A trial of MRI-targeted prostate biopsy compared cognitive fusion and software-based fusion for detection of clinically significant prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results